[1]
Tarasov, V.V.; Chubarev, V.N.; Ashraf, G. Md.; Dostdar, S.A.; Sokolov, A.V.; Melnikova, T.I.; Sologova, S.S.; Grigorevskich, E.M.; Makhmutova, A.; Kinzirsky, A.S.; Klochkov, S.G.; Aliev, G. How cancer cells resist chemotherapy: Design and development of drugs targeting protein-protein interactions. Curr. Top. Med. Chem., 2019, 19(6), 394-412.
[2]
Athanasios, A.; Stylianos, C.; Perveen, A.; Hafeez, A.; Ashraf, G. Md. Algorithmic and stochastic representations of gene regulatory networks and protein-protein interactions. Curr. Top. Med. Chem., 2019, 19(6), 413-425.
[3]
Balasubramanian, K.; Gupta, S.P. Quantum molecular dynamics, topological, group theoretical and graph theoretical studies of protein-protein interactions. Curr. Top. Med. Chem., 2019, 19(6), 426-443.
[4]
Al-Suhaimi, E.; Ravinayagam, V.; Jermy, B.R.; Mohamad, T.; Elaissari, A. Protein/hormone based nanoparticles as carriers for drugs targeting protein-protein interactions. Curr. Top. Med. Chem., 2019, 19(6), 444-456.
Current Topics in Medicinal Chemistry
Title:Design and Development of Drugs Targeting Protein-Protein Interactions – Part-I
Volume: 19 Issue: 6
Author(s): Satya P. Gupta
Affiliation:
Export Options
About this article
Cite this article as:
Gupta P. Satya , Design and Development of Drugs Targeting Protein-Protein Interactions – Part-I, Current Topics in Medicinal Chemistry 2019; 19 (6) . https://dx.doi.org/10.2174/156802661906190502163737
DOI https://dx.doi.org/10.2174/156802661906190502163737 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
32
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cu-mediated synthesis of 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-1-ones as potential inhibitors of sirtuins
Letters in Drug Design & Discovery Malignancy Risk in Systemic Lupus: Recent Research and Ongoing Challenges
Current Rheumatology Reviews Gene Therapy for the Peripheral Nervous System: A Strategy to Repair the Injured Nerve?
Current Gene Therapy Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy
Current Medicinal Chemistry Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies
Current Medicinal Chemistry - Anti-Cancer Agents Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer
Current Cancer Therapy Reviews PET Tracers Based on Zirconium-89
Current Radiopharmaceuticals Recent Developments in Receptor-Selective Retinoids
Current Pharmaceutical Design Novel non-invasive Adjunctive Techniques for Early Oral Cancer Diagnosis and Oral Lesions Examination
Current Pharmaceutical Design Plant and Animal Steroids a New Hope to Search for Antiviral Agents
Current Medicinal Chemistry Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer
Current Pharmaceutical Design Current Patents on Osteoinductive Molecules for Bone Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) An Evaluation of Computational Learning-based Methods for the Segmentation of Nuclei in Cervical Cancer Cells from Microscopic Images
Current Computer-Aided Drug Design Investigation of Human Papilloma Virus Associated with Oral Cancer with an Insight into Diagnostic Approaches and Recent Patents
Recent Patents on Biomarkers Patent Annotations
Recent Patents on Anti-Cancer Drug Discovery Detection of Residual/Recurrent Cervical Disease after Successful LEEP Conization: the Possible Role of mRNA-HPV Test
Current Pharmaceutical Design Cross Talk between the Cardiovascular and Nervous Systems:Neurotrophic Effects of Vascular Endothelial Growth Factor (VEGF) and Angiogenic Effects of Nerve Growth Factor (NGF)-Implications in Drug Development
Current Pharmaceutical Design Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
Current Medicinal Chemistry